Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
TON Strategy Company Sets First Quarter 2026 Conference Call for Tuesday, May 12, 2026 at 9:00 a.m. ET
-
Abacus Chairman and CEO to Speak at the Milken Institute Global Conference in Los Angeles
-
InVitria Showcases Exbumin® and Optibumin® 25 at IPEC Excipient World: Biologics Summit: Recombinant Human Serum Albumins Already Used in On-Market Approved Biologics
-
Phathom Pharmaceuticals to Highlight VOQUEZNA® (vonoprazan) at DDW 2026 Annual Meeting
-
WRAP® Expands Domestic Adoption of Non-Lethal Response™ Solutions with Purchase Order from Carolina Beach Police Department
-
Winnebago Industries Appoints Emily Silver to Board of Directors
-
Nova Leap Health Corp. announces Closing of Strategic Acquisition in Nova Scotia
-
Smart Circle Expands Face-to-Face Marketing Network Across North America to Meet Rising Demand for In-Person Customer Engagement
-
Kayne Anderson Energy Infrastructure Fund Announces Distribution of $0.085 Per Share for May 2026
-
IES Holdings Reports Fiscal 2026 Second Quarter Results
-
Form 8.3 - Animalcare Group plc - Octopus Investments
-
Form 8.3 - Advanced Medical Solutions Group plc - Octopus Investments
-
Based Eggman Announces Stage 3 Presale Progress
-
Spirit Blockchain Capital Inc. Files 2025 Audited Financial Statements and Provides Corporate Update
-
CoinShares Announces FY2025 Results Reflecting Continued Strong Growth
-
InflaRx to Report First Quarter 2026 Results on May 7, 2026
-
Stock Yards Bancorp Completes Acquisition of Field & Main Bancorp
-
Gildan Activewear Reports on Shareholders’ Voting Results
-
Rekor Systems to Announce First Quarter Fiscal 2026 Results
-
Abaxx Announces the Formation of Abaxx Labs and the Release of an Open-Source Library for Agentic Identity: Agents++
-
Griffin Seafoot Named Champions of Tomorrow Scholarship Recipient by Papa Johns Canada and the CHL
-
Based Eggman Announce Presale Growth amid Memecoin Rally
-
Axsome Therapeutics Hosts AUVELITY® FDA Approval Investor Event Featuring Expert Thought Leader
-
Exhale Wellness Ranked No. 1 THCA flower Online by Yucatan Magazine
-
Zapdos Labs Raises $500K to Bring AI Video Agents to Factory Floors
-
Chicago Atlantic BDC, Inc. Announces 2026 Annual Meeting of Stockholders' Date
-
PPHC Expands MultiState Associates' Stakeholder Engagement Capabilities
-
Form 8.3 Picton Property Income Limited
-
Shenandoah Telecommunications Company Reports First Quarter 2026 Results
-
MEDIA ADVISORY: VertiPorts by Atlantic to Host Electric Air Taxi Flight Demonstration with Joby Aviation at NYC’s East 34th Street Heliport on Friday May 1, 2026
-
Chicago Atlantic BDC, Inc. Announces 2026 Annual Meeting of Stockholders' Date
-
OTC Markets Group Welcomes Silver Viper Minerals Corp. to OTCQX
-
G.L. Hunt Foundation Repair CEO Hayden Slack Honored in Fort Worth Magazine’s 2026 “40 Under 40”
-
Esperion to be Acquired by ARCHIMED
-
MapLight Therapeutics Announces Completion of Enrollment in ZEPHYR Phase 2 Trial and Updates Expected Timing of Topline Results
-
Sachem Capital Sets Date for First Quarter 2026 Earnings Release and Conference Call
-
Noema Pharma to Present Phase 2a Results for Cendifensine in Vasomotor Symptoms (Hot Flashes) Due to Menopause at the 2026 ACOG Annual Clinical & Scientific Meeting
-
Molecular Partners publishes Phase 1 MP0317 data in Nature Cancer demonstrating tumor-localized CD40 activation and tumor microenvironment remodeling
-
OIO Group Announces New Leadership, Board Appointments and Strategic Roadmap for Ultra-Luxury Mobility Platform
-
PPHC Expands MultiState Associates' Stakeholder Engagement Capabilities
-
MADD Canada’s Advocacy Day Brings Victims and Survivors to Parliament Hill to Advocate for Anti-Impaired Driving Technology
-
UNISYNC Corp. Reports Q2 Fiscal 2026 Results
-
Form 8.3 LondonMetric Property Plc & Schroder REIT Limited
-
Form 8.3 Bluefield Solar Income Fund Ltd.
-
Perella Weinberg Reports First Quarter 2026 Results
-
Pluristyx and Qkine Announce a Reciprocal Distribution Agreement in Support of Optimized Growth Factor Differentiation of Induced Pluripotent Stem Cell (iPSC)
-
Brookfield Renewable Reports Record First Quarter Results
-
Rhythm Pharmaceuticals Announces IMCIVREE® (Setmelanotide) Granted Marketing Authorization by European Commission for the Treatment of Obesity and Control of Hunger in Patients with Acquired Hypothal
-
Form 8.3 Augmentum Fintech Plc
-
Wabash Announces First Quarter 2026 Results

